BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,532,000 | +6.7% | 29,981 | +2.8% | 0.03% | +13.8% |
| Q2 2022 | $4,248,000 | +29.6% | 29,157 | +5.4% | 0.03% | +61.1% |
| Q1 2022 | $3,279,000 | -19.6% | 27,653 | -6.6% | 0.02% | -10.0% |
| Q4 2021 | $4,079,000 | -3.7% | 29,600 | -2.9% | 0.02% | -13.0% |
| Q3 2021 | $4,235,000 | +44.1% | 30,485 | +0.7% | 0.02% | +130.0% |
| Q2 2021 | $2,939,000 | +39.8% | 30,274 | -1.6% | 0.01% | +42.9% |
| Q1 2021 | $2,102,000 | -21.0% | 30,753 | -0.9% | 0.01% | -30.0% |
| Q4 2020 | $2,660,000 | +42.2% | 31,039 | +7.9% | 0.01% | +11.1% |
| Q3 2020 | $1,870,000 | -11.4% | 28,771 | -0.3% | 0.01% | -10.0% |
| Q2 2020 | $2,110,000 | +144.8% | 28,856 | +13.9% | 0.01% | +100.0% |
| Q1 2020 | $862,000 | -35.3% | 25,327 | +3.4% | 0.01% | 0.0% |
| Q4 2019 | $1,333,000 | +29.4% | 24,491 | -0.8% | 0.01% | +25.0% |
| Q3 2019 | $1,030,000 | +11.1% | 24,698 | +16.7% | 0.00% | 0.0% |
| Q2 2019 | $927,000 | -9.6% | 21,170 | +6.3% | 0.00% | 0.0% |
| Q1 2019 | $1,025,000 | +48.1% | 19,922 | +6.5% | 0.00% | +33.3% |
| Q4 2018 | $692,000 | -2.3% | 18,706 | -0.8% | 0.00% | +50.0% |
| Q3 2018 | $708,000 | +0.6% | 18,849 | +5.8% | 0.00% | 0.0% |
| Q2 2018 | $704,000 | +34.6% | 17,808 | -12.3% | 0.00% | 0.0% |
| Q1 2018 | $523,000 | +173.8% | 20,303 | +187.1% | 0.00% | +100.0% |
| Q4 2017 | $191,000 | -23.9% | 7,072 | +5.5% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +61.9% | 6,706 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $155,000 | – | 6,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |